(Q57544660)
Statements
A double-blind, placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures. Vigabatrin Protocol 024 Investigative Cohort (English)
M Mosier
S Walker
K Sommerville
article